Related Experiment Video
Updated: May 29, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Discovery of a novel series of cyclic urea as potent CCR5 antagonists
Maosheng Duan1, Wieslaw M Kazmierski, Matt Tallant
1Infectious Disease Medicine Discovery and Development, GlaxoSmithKline Five Moore Drive, Research Triangle Park, NC 27706, USA.
Abstract:
A novel series of cyclic urea-based CCR5 antagonists was designed aiming to resolve instability issue in the fasted simulated intestinal fluid (FSIF) associated with the acyclic urea moiety in 1. This class of CCR5 compounds demonstrated high antiviral activities against HIV-1 infection in both HOS and PBL assays. Further evaluation of these compounds indicated that 16-R not only substantially enhanced its stability, but also exhibited excellent pharmacokinetics properties.
More Related Videos
Related Concept Videos
Urea Cycle
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Preparation of Amines: Reductive Amination of Aldehydes and Ketones

